These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 321136)

  • 1. Target cells for the activity of a synthetic adjuvant: muramyl dipeptide.
    Löwy I; Bona C; Chedid L
    Cell Immunol; 1977 Mar; 29(1):195-9. PubMed ID: 321136
    [No Abstract]   [Full Text] [Related]  

  • 2. On the mechanism of early recovery of specifically depleted lymphoid cell populations by nonspecific activation of T cells.
    Prunet J; Birrien JL; Panijel J; Liacopoulos P
    Cell Immunol; 1978 Apr; 37(1):151-61. PubMed ID: 306882
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo regulation of humoral and cellular immune responses of mice by a synthetic adjuvant, N-acetyl-muramyl-L-alanyl-D-isoglutamine, muramyl dipeptide for MDP.
    Leclerc C; Juy D; Bourgeois E; Chedid L
    Cell Immunol; 1979 Jun; 45(1):199-206. PubMed ID: 313275
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant effect of endotoxin; antibody response to sheep erythrocytes in mice after transfer of syngeneic lymphoid cells treated with bacterial lipopolysaccharide in vitro.
    Nakano M; Uchiyama T; Saito K
    J Immunol; 1973 Feb; 110(2):408-13. PubMed ID: 4567393
    [No Abstract]   [Full Text] [Related]  

  • 5. The macrophage, target cell of the synthetic adjuvant muramyl dipeptide.
    Fevrier M; Birrien JL; Leclerc C; Chedid L; Liacopoulos P
    Eur J Immunol; 1978 Aug; 8(8):558-62. PubMed ID: 359336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adjuvant activity of synthetic N-acetylmuramyl-dipeptide: evidence of initial target cells for the adjuvant activity.
    Sugimura K; Uemiya M; Saiki I; Azuma I; Yamamura Y
    Cell Immunol; 1979 Mar; 43(1):137-49. PubMed ID: 313841
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of a synthetic adjuvant on the induction of primary immune responses in T cell-depleted spleen cultures.
    Watson J; Whitlock C
    J Immunol; 1978 Jul; 121(1):383-9. PubMed ID: 307582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Status of T- and B-cell cooperation in radiation chimeras: evidence for a suppressor effect.
    Gengozian N; Urso P
    Transplant Proc; 1976 Dec; 8(4):631-5. PubMed ID: 793116
    [No Abstract]   [Full Text] [Related]  

  • 9. Lymphoid cell interactions in cell-mediated immunity.
    Dennert G; Lennox ES
    Adv Exp Med Biol; 1973; 29(0):157-66. PubMed ID: 4546858
    [No Abstract]   [Full Text] [Related]  

  • 10. Antigen recognition. 3. Effect of phytomitogens on antigen-receptor capping and the immune response in vitro.
    Lee KC; Langman RE; Paetkau VH; Diener E
    Eur J Immunol; 1973 May; 3(5):306-9. PubMed ID: 4586164
    [No Abstract]   [Full Text] [Related]  

  • 11. Macrophage-stimulating effect of a synthetic muramyl dipeptide and its adjuvant-active and -inactive analogs for the production of T-cell activating monokines.
    Iribe H; Koga T; Onoue K; Kotani S; Kusumoto S; Shiba T
    Cell Immunol; 1981 Oct; 64(1):73-83. PubMed ID: 7028277
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunoadjuvant properties of chitosan.
    Marcinkiewicz J; Polewska A; Knapczyk J
    Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):127-32. PubMed ID: 1804042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of MDP and of some analogous synthetic glycopeptides on the in vitro mouse spleen cell viability and immune response to sheep erythrocytes.
    Leclerc C; Löwy I; Chedid L
    Cell Immunol; 1978 Jul; 38(2):286-93. PubMed ID: 567100
    [No Abstract]   [Full Text] [Related]  

  • 14. Control of the mitogenicity of muramyl dipeptide.
    Wood DD; Staruch MJ
    Int J Immunopharmacol; 1981; 3(1):31-44. PubMed ID: 6975247
    [No Abstract]   [Full Text] [Related]  

  • 15. Antigen recognition by T lymphocytes. IV. Differences in antigen-binding characteristics of T- and B-RFC: a cause for variations in the evaluation of T-RFC.
    Charreiré J; Dardenne M; Bach JF
    Cell Immunol; 1973 Oct; 9(1):32-44. PubMed ID: 4542693
    [No Abstract]   [Full Text] [Related]  

  • 16. T cell deficiency in mouse allogeneic radiation chimeras.
    Urso P; Gengozian N
    J Immunol; 1973 Sep; 111(3):712-9. PubMed ID: 4582262
    [No Abstract]   [Full Text] [Related]  

  • 17. Stimulation of the in vivo dinitrophenyl antibody response to the DNP conjugate of L-glutamic acid60-L-alanine30-L-Tyrosine10 (GAT) polymer by a synthetic adjuvant, muramyl dipeptide (MDP): target cells for adjuvant activity and isotypic pattern of MDP-stimulated response.
    Lowy I; Theze J; Chedid L
    J Immunol; 1980 Jan; 124(1):100-4. PubMed ID: 6965289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of erythrocyte antigen structure on requirement for T cells.
    Byrd W; Feldmann M; Palmer J
    Immunology; 1974 Aug; 27(2):331-7. PubMed ID: 4138234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spleen and antibody formation].
    Bürki H; Luscieti P; Pedrinis E; Schädeli J; Hess MW; Cottier H
    Schweiz Med Wochenschr; 1974 Sep; 104(39):1351-60. PubMed ID: 4607935
    [No Abstract]   [Full Text] [Related]  

  • 20. B-Lymphocyte differentiation in lethally irradiated and reconstituted mice. II. Recovery of humoral immune responsiveness.
    Rozing J; Brons NH; Benner R
    Cell Immunol; 1977 Mar; 29(1):37-53. PubMed ID: 321137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.